Literature DB >> 20617467

Development of screening tools to identify psoriatic arthritis.

Patrick Dominguez1, Dafna D Gladman, Philip Helliwell, Philip J Mease, M Elaine Husni, Abrar A Qureshi.   

Abstract

Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis that follows an indolent and progressive course. A delay in diagnosis and treatment may lead to irreversible changes such as erosive arthritis, which lead to permanent physical disability and deformity. Administration of a well-designed screening tool can increase detection of PsA and help determine the prevalence of PsA in a given population. Several tools have been developed to help clinicians screen for PsA. Members of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis recently led an effort to develop and validate three PsA screening tools: the Psoriatic Arthritis Screening and Evaluation tool, the Psoriasis Epidemiology Screening Tool, and the Toronto Psoriatic Arthritis Screen.

Entities:  

Mesh:

Year:  2010        PMID: 20617467     DOI: 10.1007/s11926-010-0113-2

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  11 in total

1.  Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire.

Authors:  Gerd-Marie Alenius; Berndt Stenberg; Hans Stenlund; Magnus Lundblad; Solbritt Rantapää Dahlqvist
Journal:  J Rheumatol       Date:  2002-12       Impact factor: 4.666

2.  New topical treatments change the pattern of treatment of psoriasis: dermatologists remain the primary providers of this care.

Authors:  S R Feldman; A B Fleischer; J Z Cooper
Journal:  Int J Dermatol       Date:  2000-01       Impact factor: 2.736

3.  Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire.

Authors:  G H Ibrahim; M H Buch; C Lawson; R Waxman; P S Helliwell
Journal:  Clin Exp Rheumatol       Date:  2009 May-Jun       Impact factor: 4.473

4.  Classification criteria for psoriatic arthritis: development of new criteria from a large international study.

Authors:  William Taylor; Dafna Gladman; Philip Helliwell; Antonio Marchesoni; Philip Mease; Herman Mielants
Journal:  Arthritis Rheum       Date:  2006-08

Review 5.  Diagnosis and management of psoriatic arthritis.

Authors:  John Brockbank; Dafna Gladman
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 6.  Psoriatic arthritis.

Authors:  D D Gladman; J Brockbank
Journal:  Expert Opin Investig Drugs       Date:  2000-07       Impact factor: 6.206

Review 7.  Diagnosis and treatment of psoriatic arthritis.

Authors:  Philip Mease; Bernard S Goffe
Journal:  J Am Acad Dermatol       Date:  2005-01       Impact factor: 11.527

8.  Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS).

Authors:  D D Gladman; C T Schentag; B D M Tom; V Chandran; J Brockbank; C Rosen; V T Farewell
Journal:  Ann Rheum Dis       Date:  2008-04-29       Impact factor: 19.103

Review 9.  Prevalence of joint disease in patients with psoriasis: implications for therapy.

Authors:  Hugh Zachariae
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

10.  The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool.

Authors:  M Elaine Husni; Kathryn H Meyer; Darel S Cohen; Elinor Mody; Abrar A Qureshi
Journal:  J Am Acad Dermatol       Date:  2007-07-03       Impact factor: 11.527

View more
  9 in total

Review 1.  The Epidemiology of Psoriatic Arthritis.

Authors:  Alexis Ogdie; Pamela Weiss
Journal:  Rheum Dis Clin North Am       Date:  2015-09-11       Impact factor: 2.670

2.  A resistance exercise program improves functional capacity of patients with psoriatic arthritis: a randomized controlled trial.

Authors:  Diego Roger-Silva; Jamil Natour; Emilia Moreira; Fabio Jennings
Journal:  Clin Rheumatol       Date:  2017-11-28       Impact factor: 2.980

Review 3.  Comorbidity in Adult Psoriasis: Considerations for the Clinician.

Authors:  Christine Daugaard; Lars Iversen; Kasper Fjellhaugen Hjuler
Journal:  Psoriasis (Auckl)       Date:  2022-06-10

4.  Developing the Thai Siriraj Psoriatic Arthritis Screening Tool and validating the Thai Psoriasis Epidemiology Screening Tool and the Early Arthritis for Psoriatic Patients questionnaire.

Authors:  Praveena Chiowchanwisawakit; Luksame Wattanamongkolsil; Varalak Srinonprasert; Chonachan Petcharat; Palanan Siriwanarangsun; Wanruchada Katchamart
Journal:  Rheumatol Int       Date:  2016-06-22       Impact factor: 2.631

5.  A novel, short, and simple screening questionnaire can suggest presence of psoriatic arthritis in psoriasis patients in a dermatology clinic.

Authors:  N Garg; B Truong; J H Ku; T S Devere; B D Ehst; A Blauvelt; A A Deodhar
Journal:  Clin Rheumatol       Date:  2014-05-15       Impact factor: 2.980

Review 6.  Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives.

Authors:  Wolf-Henning Boehncke; Sandra Boehncke
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

7.  How can psoriatic arthritis be diagnosed early?

Authors:  Amir Haddad; Vinod Chandran
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

8.  Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers.

Authors:  Daniela Cretu; Kun Liang; Punit Saraon; Ihor Batruch; Eleftherios P Diamandis; Vinod Chandran
Journal:  Clin Proteomics       Date:  2015-01-13       Impact factor: 3.988

Review 9.  Recent advances in understanding and managing psoriatic arthritis.

Authors:  Dafna D Gladman
Journal:  F1000Res       Date:  2016-11-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.